Skip to content
Search

Latest Stories

‘ByeByeUTI’ pilot scheme now rolled out across England

‘ByeByeUTI’ pilot scheme now rolled out across England

Over 30,000 women have been treated for uncomplicated urinary tract infections at local pharmacies since the launch of the pilot scheme in July 2022

Local pharmacists in England can now evaluate and provide treatment for patients with uncomplicated urinary tract infections (UTIs) in women under the age of 65, without the need for a GP appointment.


The ‘ByeByeUTI’ scheme has been expanded across the country, following a successful pilot across North East and North Cumbria.

More than 30,000 women have been treated for uncomplicated urinary tract infections at local pharmacies since the pilot scheme was launched in July 2022 as part of the NHS and government’s primary care access recovery plan, according to NHS England.

The expansion of pharmacy services not only enhances patients' access to care but also frees up tens of thousands of GP appointments at the same time.

Dr Faisel Baig, Medical Director for Primary Care, NHS England North East and Yorkshire, said that the rollout of this service across the whole region will enable many more women to receive “faster and easier” access to advice and treatment.

“The expansion of pharmacy services will not only make it easier and more convenient for people to access care, but also help free up more GP appointments every year, so people can get the care they need more quickly,” he added.

Ewan Maule, Director of Medicines and Pharmacy for NHS North East and North Cumbria Integrated Care Board (ICB) expressed satisfaction that the success of ‘ByeByeUTI’ pilot scheme in their region has led to the expansion of this service nationwide.

“Local pharmacies are at the heart of our communities and this will make it quicker and easier for women to access advice and treatment for a UTI – offering a faster and more convenient way to get the medication they need,” he said.

Under the newly launched Pharmacy First service, patients can visit their local pharmacy to get treatment for sinusitis, sore throat, earache, infected insect bite, impetigo, and shingles – in addition to UTIs – without the need to see a GP.

More For You

Mike Hewitson, superintendent pharmacist & managing director of Beaminster Pharmacy

Mike Hewitson elected as NPA board member for England

Mike Hewitson elected as NPA board member for England: New term begins April

Mike Hewitson, superintendent pharmacist & managing director ofBeaminster Pharmacy, has been elected as the next National Pharmacy Association (NPA) board member for England.

Since 2023, Hewitson has served as chair of Community Pharmacy Dorset. He is also a member of Somerset Council and a Non-Executive Director at HubRx.

Keep ReadingShow less
Store closures 2024: Chemists among hardest hit

Over 600 chemist shops belonging to multiples and chains were closed last year

Getty Images

35 shops closed per day last year, chemists worst affected

More shops are expected to exit the UK high streets driven by driven by rising operational costs and a continued shift towards online shopping and transactions.

According to figures from PwC, a total of 12,804 outlets operated by chains (those with five or more locations) exited high streets, shopping centres and retail parks in 2024 – equivalent to 35 closures per day.

Keep ReadingShow less
Empty pharmacy shelves due to UK medicine shortages.

The government has said it's investing up to £520m to manufacture more medicines

Pic credit: iStock

Brexit blamed for UK medicine shortages with "little sign of recovery"

The UK is facing “a worsening situation” with drugs shortages compared to the rest of Europe as a result of Brexit, according to the Nuffield Trust health thinktank.

It comes of the back of data that revealed that the department of health and social care (DHSC) received 1,938 notifications of disruptions to medicine supply last year – the highest in four years.

Keep ReadingShow less
Alert! Patients on Promixin should be switched to alternatives by 30 April

Promixin is licensed for treating chronic pulmonary infections caused by Pseudomonas aeruginosa in adults and children with cystic fibrosis

Getty Images

Medicine shortage: Promixin to be discontinued from May 2025

The Department of Health and Social Care (DHSC) and NHS England have issued a national patient safety alert regarding the upcoming shortage of Promixin (colistimethate).

The alert, issued on 17 March 2025, states that Promixin (colistimethate) 1-million-unit powder for nebuliser solution unit dose vials (UDVs) will be discontinued from early May 2025, with stocks expected to be exhausted by this time.

Keep ReadingShow less
PAGB welcomes new vice-presidents and treasurer to Board

Rob Elliott and Bas Vorsteveld ( L-R)

Bas Vorsteveld will now oversee the Kenvue’s business in Northern Europe

PAGB appoints new vice-presidents and treasurer to Board

PAGB, the consumer healthcare association, has announced the appointment of two new vice-presidents and a treasurer to their Board.

Bas Vorsteveld, area managing director for Northern Europe at Kenvue, and Rob Elliott, OTC centre of excellence lead at Viatris, have been elected as vice-presidents.

Keep ReadingShow less